Pipeline Portfolio
For further information or quotations please contact our Sales Department by emailing apis@uquifa.com or using the contact form.
Product | Use | Site | Phase |
---|---|---|---|
APIXABAN | Antithrombotic | India | Scale Up |
BRIVIRACETAM | Antiepilepsy | India | Validation |
CARIPRAZINE | Antipsychotic | India | Scale Up |
CIPROFLOXACIN BASE | Antibiotic | Mexico | Validation |
EDOXABAN | Cardiovascular | India | Scale Up |
KETAMINE HCl | Anesthetic | Spain | Under development |
LASMIDITAN | Migraine | India | Scale Up |
LEVOKETOCONAZOLE | Cushing's syndrome | India | Under development |
MIRABEGRON | Overactive bladder | Mexico | Scale Up |
OXCARBAZEPINE | Antiepelipsy | Mexico | Under development |
PRAZIQUANTEL | Antihelmintics | Mexico | Under development |
PROPOFOL | Anesthetic | Mexico | Scale Up |
QUINFAMIDE | Treatment of Amoebiasis | Mexico | Under development |
RICOBENDAZOLE | Anthelmintic | Mexico | Validation |
RIVAROXABAN | Anticoagulant | Spain | Scale Up |

Headquarters
UQUIFA Group
Carrer Mallorca 262, 3º
08008 Barcelona
Spain
Phone: +34 934 674 810
Legal Compliance
Work with us
Contact us